Search

Your search keyword '"Fernandez, A. I."' showing total 2,462 results

Search Constraints

Start Over You searched for: Author "Fernandez, A. I." Remove constraint Author: "Fernandez, A. I."
2,462 results on '"Fernandez, A. I."'

Search Results

158. Luttinger liquid with asymmetric dispersion

159. Non local Thirring model with backward and umklapp interactions

165. Friedel oscillations in a Luttinger liquid with long-range interactions

166. Fabrication of fluidic devices with 30 nm nanochannels by direct imprinting

167. Field-theory computation of charge-density oscillations in a Tomonaga-Luttinger model with impurities

168. A System to study the Evolution of Cardiac Arrhythmias at Home

169. Study of Calcined Mixtures from Industrial Residues for Production of Agglomerates

171. Bilateral Subdiaphragmatic Vagal Nerve Stimulation Using a Novel Waveform Decreases Body Weight, Food Consumption, Adiposity, and Activity in Obesity-Prone Rats

172. Major cardiovascular events in patients with atrial fibrillation and active lung cancer: data from the CANAC-FA registry, a multicentre, retrospective, observational study

173. Impact of cardiovascular events and major bleeding in mortality in patients with atrial fibrillation and active lung cancer: data from a multicentre, retrospective, observational study

174. Frailty prevalence among older decompensated heart failure patients

179. Path-integral formulation of backward and umklapp scattering for 1d spinless fermions

186. Whole-genome sequencing of European autochthonous and commercial pig breeds allows the detection of signatures of selection for adaptation of genetic resources to different breeding and production systems

187. Functional integral approach to multipoint correlators in 2d critical systems

194. FIGURE 4 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

195. FIGURE 3 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

196. Supplementary Figure 2 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

197. Supplementary Table 5 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

198. Supplementary Table 1 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

199. Supplementary Figure 4 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

200. Supplementary Table 2 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Catalog

Books, media, physical & digital resources